This final article discussing highlights from SABCS 2022 summarizes some of the presentations that did not fit in the categories discussed earlier. This summary will address the results of three clinical trials evaluating neoadjuvant treatment strategies in HER2-negative early breast cancer together with the data from the POSITIVE trial, evaluating the safety of interrupting endocrine therapy to facilitate pregnancy panning in younger women with breast cancer.